# Big Health

received FDA clearance for SleepioRx in August 2024 and for DaylightRx in September 2024, the first FDA-cleared non-drug treatment for generalized anxiety disorder, and raised $23.7 million in February 2026 to scale commercial expansion following new CMS reimbursement codes for digital mental health treatments.

Source: https://en.bioecon.ru/companies/big-health/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Digital therapeutics](https://en.bioecon.ru/technology/digital-therapeutics/)